Neoadjuvant Camrelizumab Followed by Concurrent Camrelizumab Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: a Single-Arm, Phase II Study
JOURNAL OF THORACIC DISEASE(2024)
Key words
Locally advanced esophageal squamous cell carcinoma (locally advanced ESCC),neoadjuvant immunotherapy,camrelizumab,chemotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined